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There are several gene variants that are candidates to influence functional capacity
in long-lived individuals. As such, their potential association with exceptional longevity
(EL, i.e., reaching 100+ years) deserves analysis. Among them are rs7832552 in the
thyrotropin-releasing hormone receptor (TRHR) gene, rs1800795 in the interleukin-6 (IL6)
gene and rs6552828 in the coenzyme A synthetase long-chain 1 (ACSL1) gene. To
gain insight into their functionality (which is yet unknown), here we determined for the
first time luciferase gene reporter activity at the muscle tissue level in rs7832552 and
rs6552828. We then compared allele/genotype frequencies of the 3 abovementioned
variants among centenarians [n = 138, age range 100–111 years (114 women)] and
healthy controls [n = 334, 20–50 years (141 women)] of the same ethnic and geographic
origin (Spain). We also studied healthy centenarians [n = 79, 100–104 years (40 women)]
and controls [n = 316, 27–81 years (156 women)] from Italy, and centenarians [n = 742,
100–116 years (623 women)] and healthy controls [n = 499, 23–59 years (356 women)]
from Japan. The THRH rs7832552 T-allele and ACSL1 rs6552828 A-allele up-regulated
luciferase activity compared to the C and G-allele, respectively (P = 0.001). Yet we found
no significant association of EL with rs7832552, rs1800795 or rs6552828 in any of the 3
cohorts. Further research is needed with larger cohorts of centenarians of different origin
as well as with younger old people.
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Introduction
The oldest old population (≥85 years) is rapidly expanding
among westerners (Waite, 2004; Robine and Paccaud, 2005).
However, aging is associated with an increased risk of loss of
functional independence (Christensen et al., 2008). In this regard,
centenarians (people aged 100+ years) are the paradigm of
healthy aging, as they have usually postponed (or even avoided,
in some cases) major age-related diseases, as well as the onset of
disability, until they were well into their nineties (Terry et al.,
2008). Thus, the search for the gene variants that might influence
the likelihood of reaching exceptional longevity (EL, i.e., becom-
ing a centenarian) might help identify targets of “anti-aging”
interventions.
In old people, functional independence is dependent on phys-
ical fitness, which in turn is determined by several phenotypes
such as mainly cardiorespiratory fitness and muscle performance
(Garber et al., 2011). Concerning the latter, aging is inevitably
associated with a decline in muscle mass and function, i.e., sar-
copenia, with an acceleration of this process increasing the risk
of mortality (Metter et al., 2004; Ruiz et al., 2008). Thus, those
gene variations that can be associated with preservation of mus-
cle mass/function at advanced ages, e.g., the K153R polymor-
phism in the myostatin (MSTN) gene (Garatachea et al., 2013a)
or the I/D polymorphism in the angiotensin converting enzyme
(ACE) (Garatachea et al., 2013b) as well as other genetic varia-
tions linked with muscle aerobic capacity (e.g., the R577X muta-
tion in the α-actinin-3 (ACTN3) gene), might also influence the
likelihood of reaching EL (Fiuza-Luces et al., 2011).
There are other potential candidates to influence muscle phe-
notypes in long-lived individuals and as such their potential
association with EL deserves analysis. In this regard, a recent
genome wide scan (GWAS) analysis of 379,319 SNPs in US
Caucasians of both genders (aged 50 years on average) revealed
an association of lean body mass with 2 SNPs in tight link-
age disequilibrium within the thyrotropin-releasing hormone
receptor (TRHR) gene, rs16892496 and rs7832552 (Liu et al.,
2009). These results were further corroborated in independent
cohorts of older Caucasians of both genders, aged 63 (men) and
61 years (women). The functional significance of these 2 vari-
ants remains however to be determined. Another candidate is
the −174C/G polymorphism (rs1800795) in the interleukin-6
(IL6) gene, where the G-allele is associated with higher transcrip-
tion in vitro (Fishman et al., 1998) and in vivo conditions (Ben-
nermo et al., 2004). IL6 is a multifunctional cytokine that might
be also involved in muscle regeneration (Serrano et al., 2008).
Pereira et al recently found that the GG genotype, which is asso-
ciated with lower IL6 levels and thus with “anti-inflammatory”
profile, was associated with better physical performance in
community-dweller elderly women (≥65 years) (Pereira et al.,
2013).
As for cardiorespiratory fitness [which is usually determined
with peak oxygen uptake (VO2peak)], a recent GWAS study
in sedentary Caucasians found that, among 324,611 SNPs, the
strongest association with the VO2peak response to exercise was
found to acyl coenzyme A synthetase long-chain 1 (ACSL1) gene
polymorphism rs6552828 (Bouchard et al., 2011). The ACSL1
gene is a candidate to explain individual variability in VO2peak,
as well as in some health-related phenotypes, owing to its poten-
tial role in aerobic metabolism at the adypocyte, cardiomy-
ocyte, liver and skeletal muscle fiber level (Martin et al., 1997;
Coleman et al., 2000; Hall et al., 2003; Mashek et al., 2006;
Ellis et al., 2010), yet its functional significance has not been
assessed.
In order to analyze their functionality at the muscle level, we
measured for the first time luciferase gene reporter activity in
TRHR rs16892496 and rs7832552, and also in ACSL1 rs6552828.
Only rs7832552 in the TRHR gene was genotyped in this study
because it is in tight linkage disequilibrium with rs16892496 (Liu
et al., 2009). Based on the hypothesis that common genetic poly-
morphisms influencing physical fitness may also have an impact
on the ability to reach EL, we then compared allele/genotype fre-
quencies of the abovementioned SNPs—together with the IL6
rs1800795 SNP (whose functional significance is already known,
as mentioned above)—among Spanish centenarians (cases) and
healthy controls matched by ethnic and geographic origin and
also in 2 other geographically and ethnically-independent repli-
cation cohorts (from Italy and Japan).
Methods
Functional Analysis: Luciferase Reporter Gene
The fragment, including the allele, was directly inserted into the
pGL3-promoter at the restriction recognition sites MluI/NheI in
the 5′ and XhoI in the 3′ (see below -in bold) of the sequences
obtained from the genomes of:
(i) one individual homozygous for the rs16892496 A-allele and
one individual homozygous for the rs16892496 C-allele (see
below -underlined)
rs16892496 AA
GCTAGCTATGAAAGATCTACGTTAAAACATAAGGTT
AAGCTGTGCAGTGTACAGAAGAGACAAGAAAGTGG
TACTTACTGTGCATAAGGTTGAAGAGCAAGCCCCCA
GTGGGATACAAGTCACTCTCAGGCTTGAAAAATGAG
TAGGCATTCACTAGGCCAACATAAAATACAAGAAGA
CCCTCCAGTCTGCAGAAGTAGTCAATGACTCGAG
rs16892496 CC
GCTAGCTATGAAAGATCTACGTTAAAACATAAGGTT
AAGCTGTGCAGTGTACAGAAGAGACAAGAAAGTGG
TACTTACTGTGCATAAGGTTGAAGAGCAAGCCCCCC
GTGGGATACAAGTCACTCTCAGGCTTGAAAAATGAG
TAGGCATTCACTAGGCCAACATAAAATACAAGAAGA
CCCTCCAGTCTGCAGAAGTAGTCAATGACTCGAG
(ii) one individual homozygous for the rs7832552 C-allele and
one homozygous for the rs7832552 T-allele (see below -
underlined)
rs7832552-CC
GAGCTCATTAGCCTTGTGACAAAAGCAACGCACTCC
ATTTTGCACACAGTACTTGACTTTATTTTGCTACTGC
CTTGACCTCAAAGGAATGTGATAGTGTGAGGTACGA
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ATGCTCTTAATAAACAGGATCGATCAAGGGTGCTTG
ACTCTTGTTGTTCATGTGCAAGTATAGTGGCTTTTT
TGTGCCTCAACAAAACCATCAAGAGTCTCGAG
rs7832552-TT
GAGCTCATTAGCCTTGTGACAAAAGCAACGCACTCC
ATTTTGCACACAGTACTTGACTTTATTTTGCTACTGC
CTTGACCTCAAAGGAATGTGATAGTGTGAGGTATGA
ATGCTCTTAATAAACAGGATCGATCAAGGGTGCTTGA
CTCTTGTTGTTCATGTGCAAGTATAGTGGCTTTTTTG
TGCCTCAACAAAACCATCAAGAGTCTCGAG
(iii) one individual homozygous for the rs6552828 A-allele and
one individual homozygous for the rs6552828 G-allele (see
below -underlined)
rs6552828-AA
GAGCTCCAAGACATTATAGCCAAAAGAAACAAACAG
ATAAATTGGTGTGCATAAACTTTAAACCAACCACCAG
ATATCTAAAGAGGGAATACAGCACAGTGTTGGAAAG
AAAGTACAGAATAGTATTTGAGATCCTAGATGCAGC
CGGACGCGGTGGCTCATGCCTGTAATCCCAGCACTT
TGGGAAGCCGAGGCGGGTGGATCACCCTCGAG
rs6552828-GG
GAGCTCCAAGACATTATAGCCAAAAGAAACAAACAG
ATAAATTGGTGTGCATAAACTTTAAACCAACCACCAG
ATATCTAAAGAGGGAATACAGCACAGTGTTGGAGAG
AAAGTACAGAATAGTATTTGAGATCCTAGATGCAGC
CGGACGCGGTGGCTCATGCCTGTAATCCCAGCACTT
TGGGAAGCCGAGGCGGGTGGATCACCCTCGAG
We used mice skeletal muscle C2C12 cell lines to study muscle-
specific expression.We performed cell cultures, transfections and
dual-luciferase reporter assays following the procedures previ-
ously reported by our group (He et al., 2011). We used the pRL-
SV40 vector as an internal control for variations in transfection
efficiency, and the pGL3-promoter vector without an insert as a
negative control. The transfected cells were harvested after 48 h,
and assayed for firefly and renilla luciferase activity with the
dual-luciferase reporter assay system (Promega Biotech, Beijing,
China) using a luminometer following themanufacturer’s recom-
mendations (TecanGenios Pro, Männedorf, Switzerland). From
each measurement, we divided firefly by renilla luciferase activ-
ity reading to calculate relative luciferase activity. We performed
the experiments in triplicates and expressed relative luciferase
activity values as the means±SD of the 3 different measurements.
Subjects
We obtained approval from the local ethics committees [Euro-
pean University of Madrid (Spain), University of Pavia (Italy),
and National Institute of Health and Nutrition, (Japan) Med-
ical Research Institute and Keio University (Japan)] and the
study followed the tenets of the Declaration of Helsinki for
Human Research. Written consent was also obtained from each
participant.
Spanish Cohort
Two groups of Spanish subjects were assessed: (i) 138 cases
(centenarians, aged 100–111 years, 114 women); and (ii) 334
healthy controls (aged 20–50 years, 141 women). All the subjects
were of the sameCaucasian (Spanish) descent for≥3 generations.
The major diseases among the centenarians were osteoarthritis
(66%), hypertension (57%), dementia (51%) and cardiovascular
disease (CVD, 29%). The DNA of a convenience sample of 355
younger disease-free controls with no reported family history of
high longevity (>90 years) was collected during 2008-2012 in the
European University of Madrid.
Italian Cohort
Two groups of subjects from Northern Italy (mainly from Lom-
bardy and Piedmont) were studied: (i) 79 cases (healthy cente-
narians, aged 100–104 years, 40 women); and (ii) 316 healthy
controls (aged 27–81 years, 156 women). All patients and con-
trols were Caucasian whites of Italian descent for ≥3 genera-
tions The Italian centenarians were free of major age-related
diseases, i.e., severe cognitive impairment, clinically evident can-
cer, CVD, renal insufficiency or severe physical impairment
(Emanuele et al., 2010). Controls were free of CVD or cerebrovas-
cular disease, cancer, dementia, chronic autoimmune/ inflam-
matory disorders, renal or hepatic failure, and major psychiatric
conditions.
Japanese Cohort
Two groups of subjects of the same Asian (Japanese) descent
were assessed: (i) 742 cases (centenarians, aged 100–116 years,
623 women); and (ii) 499 healthy controls (aged 23–59 years, 356
women). The group of cases was gathered from 2 cohorts, which
are described in detail elsewhere (Gondo et al., 2006): the Tokyo
Centenarians Study (TCS) and the Semi-Supercentenarians
Study in Japan (SSC-J). The prevalence of hypertension, CVD
and dementia among the Japanese centenarians was of 63.6, 28.8,
and 59.4%, respectively. Controls from both genders (aged <60
years, and free of diagnosed CVD and chronic renal failure) were
recruited during years 2008–2012.
Genotyping
As mentioned above, only one THRH SNP, rs7832552, was
genotyped in the 3 cohorts (and not rs16892496) because the
genotype distributions of both SNPs are completely linked
according to available HapMap for both European and Asian
populations (sorted as a Supplementary file 1) and previous
research has shown that both SNPs are in strong linkage dise-
quilibrium (r2 = 0.98). All genotyping was performed only for
research purposes with the researchers who performed the geno-
typing being blinded to the participants’ identities. For quality
control, a random ∼20% of the samples of each cohort were
genotyped again, with no differences in the results compared with
the initial genotyping.
Spanish Cohort
DNA was extracted from the participants’ buccal cells (saliva
samples) using a standard phenol chloroform protocol and the
genotype analyses were performed in the Biomedicine labora-
tory at the European University, Madrid (Spain). The DNA
samples were diluted with sterile water and stored at −20◦C
until analysis. Genotyping was performed by Real-Time PCR
and using the TaqMan R© rs7832552, rs6552828, and rs1800795
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SNP genotyping assays with a Step One Real-Time PCR System
(Applied Biosystems, Foster City, CA).
Italian Cohort
Genomic DNA was purified from blood leukocytes using the
QiaAmp DNAMini kit (Qiagen, Hilden, Germany) according to
the manufacturer’s protocol. Genotyping was performed at the
Cellular Pathophysiology and Clinical Immunology Laboratory
(University of Pavia) using the TaqMan R© rs7832552, rs6552828,
and rs1800795 SNP genotyping assays (Applied Biosystems, Fos-
ter City, CA, USA).
Japanese Cohort
Total genomic DNA was extracted from blood leukocytes with
a QIAamp DNA Blood Mini or Maxi Kit (Qiagen, Tokyo,
Japan). Genotyping of rs7832552, rs6552828, and rs1800795 was
performed at the Institute of Health and Sports Science and
Medicine (Juntendo University) with Real Time Thermocycler
(LightCycler 480, Roche Applied Science, Mannheim, Germany)
using TaqMan SNP genotyping assay method. PCR 384-well
plates were read on LightCycler 480 using the end-point anal-
ysis mode. Allelic discrimination analysis was performed with
a LightCycler 480 SW software version 1.5.1.62 (Roche Applied
Science, Mannheim, Germany).
Statistical Analysis
One-way analysis of variance was used to compare the rela-
tive luciferase activity in the different plasmids of each SNP.
Allele frequencies were calculated by gene-counting. We tested
Hardy-Weinberg equilibrium (HWE) using χ2-test. Geno-
type/allele frequencies of cases vs. controls within each cohort
(Spanish, Italian, and Japanese) were compared using the χ2-
test with Yates’ correction and the association between geno-
types/alleles and EL within each of the 3 cohorts was analyzed
with logistic regression analysis after adjusting for sex. All sta-
tistical analyses were performed using the PASW (v. 18.0 for
WINDOWS, Chicago) and corrected for multiple comparisons
using the Bonferroni’s method -that is, the threshold P-value was
obtained by dividing 0.05 by the number of studied polymor-
phisms (P = 0.05/3 = 0.017).
Results
Functional Analysis
The results of luciferase report analyses are presented in Figure 1.
All the SNPs we studied showed functional significance, as
reflected by differences in luciferase activity between the 3 SNP
constructs (all P ≤ 0.001); the THRH rs16892496 A-allele
up-regulated luciferase activity compared to the C-allele (upper
panel), the THRH rs7832552 T-allele up-regulated luciferase
activity compared to the C-allele (middle panel), and the ACSL1
rs6552828 A-allele up-regulated luciferase activity compared to
the G-allele (lower panel).
Spanish Cohort
Rate of genotyping success was as follows: THRH rs7832552,
97.2% in cases and 100% in controls; ACSL rs6552828, 97.2%
in cases and 99.1% in controls; IL6 rs1800795, 100% in cases
FIGURE 1 | Comparison of relative luciferase activity (i.e., firefly
luciferase activity divided by renilla luciferase activity) between
plasmids for the THRH rs16892496 (upper panel), THRH rs7832552
(middle panel), and ACSL1 rs6552828 (lower panel). Values are mean ±
SD of three different experiments, each performed in triplicate. For the 3 SNPs,
statistical significance was reached for all the comparisons between plasmids
(all P ≤ 0.001).
and 94.9% in controls. The distribution of all genotypes was
consistent with the HWE in both groups (P > 0.05), except for
IL6 rs1800795 in the control group (P < 0.01).
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The results of genotype/allele frequency distributions as well
as of binary logistic regression adjusted by sex are shown in
Table 1 and summarized below. The allele (χ2 = 1.21, P = 0.27)
or genotype frequency distributions of THRH rs7832552 did not
differ between cases and controls (χ2 = 2.74, P = 0.25). Using
logistic regression analysis, no significant associations were found
between EL and rs7832552, including when analyzing both sexes
separately (data not shown). No differences were found for IL6
rs1800795 in allele (χ2 = 1.01, P = 0.32) or genotype distri-
butions (χ2 = 3.89, P = 0.14), with no significant association
with EL after adjusting for sex or when analyzing both sexes sep-
arately -data not shown) or forACSL1 rs6552828 (χ2 = 2.28, P =
0.13 for allele distribution and χ2 = 3.30, P = 0.19 for genotype
distribution, with no significant association with EL after adjust-
ing for sex or when analyzing both sexes separately -data not
shown).
Italian Cohort
Rate of genotyping success was 100% for all gene variants. The
distribution of all genotypes was consistent with theHWE in both
groups (P > 0.05), except for THRH rs7832552 in the control
group (P = 0.04).
The results of genotype/allele frequency distributions as well
as of binary logistic regression adjusted by sex are shown in
Table 2 and summarized below. The allele (χ2 = 0.003, P =
0.95) and genotype frequency distributions of THRH rs7832552
did not differ between groups (χ2 = 0.26, P = 0.88) and
no significant association was found between this polymorphism
and EL using logistic regression adjusted by sex, or when ana-
lyzing both sexes separately (data not shown). Similar results
were found for IL6 rs1800795 (allele frequency: χ2 = 0.82,
P = 0.36; genotype frequency:χ2 = 1.054, P = 0.59) andACSL1
rs6552828 (allele frequency: χ2 = 0.56, P = 0.46; genotype fre-
quency: χ2 = 0.67, P = 0.72), with no significant association
between these two polymorphisms and EL using logistic regres-
sion adjusted by sex, or when analyzing both sexes separately
(data not shown).
Japanese Cohort
Rate of genotyping success was as follows: THRH rs7832552,
97.0% in cases and 100% in controls; IL6 rs1800795, 98.7% in
cases and 100% in controls; ACSL1 rs6552828, 95.9% in cases
and 99.2% in controls. The distribution of all genotypes was con-
sistent with the HWE in both groups (P > 0.05), except for
rs6552828 in centenarians (P = 0.02).
The results of genotype/allele frequency distributions as well
as of binary logistic regression adjusted by sex are shown
in Table 3 and summarized below. We found no differences
between cases and controls for THRH rs7832552 (allele fre-
quency: χ2 = 0.012, P = 0.91; genotype frequency: χ2 =
0.592, P = 0.74), rs1800795 (allele frequency: χ2 = 0.07,
P = 0.78; genotype frequency: χ2 = 0.07, P = 0.78), or
rs6552828 (allele frequency: χ2 = 0.020, P = 0.89; genotype
frequency: χ2 = 3.78, P = 0.15), with no significant associa-
tion between any of the SNPs and EL using logistic regression
adjusted by sex or when analyzing both sexes separately (data not
shown).
TABLE 1 | Genotype/allele frequencies of THRH rs7832552, ACSL1
rs6552828 and IL6 rs1800795 and results of logistic regression analysis, in
the Spanish cohort.
Controls Cases OR 95%CI P-value
N % N %
rs7832552
Codom CC 174 52.1 61 44.2 1.00 0.14
CT 135 40.4 67 48.5 1.52 0.97–2.37
TT 25 7.5 10 7.3 1.71 0.72–4.09
Dom CC 174 52.1 61 44.2 1.00 0.048
CT-TT 160 47.9 77 55.8 1.54 1.00–2.37
Reces CC-CT 309 92.5 128 92.8 1.00 0.44
TT 25 7.5 10 7.2 1.40 0.60–3.24
Overdom CC-TT 199 59.6 71 51.5 1.00 0.11
CT 135 40.4 67 48.5 1.42 0.92–2.19
Log-additive – – – – 1.41 0.99–1.99 0.055
Allele C 483 72 189 68 1.00 0.06
T 185 28 87 32 1.37 0.98–1.97
rs6552828
Codom GG 126 38.1 65 47.1 1.00 0.41
GA 153 46.2 54 39.1 1.36 0.86–2.16
AA 52 15.7 19 13.8 1.25 0.65–2.40
Dom GG 126 38.1 65 47.1 1.00 0.19
GA-AA 205 61.9 73 52.9 1.33 0.87–2.05
Reces GG-GA 279 84.3 119 86.2 1.00 0.82
AA 52 15.7 19 13.8 1.07 0.58–1.98
Overdom GG-AA 178 53.8 84 60.9 1.00 0.83–1.99 0.25
GA 153 46.2 54 39.1 1.29 0.86–1.60
Log-additive – – – – 1.18 0.86–1.60 0.30
Allele G 405 61 184 67 1.00 0.29
A 257 39 92 33 0.84 0.61–1.15
rs1800795
Codom GG 170 53.6 65 45.5 1.00 0.20
GC 101 31.9 59 41.3 0.65 0.41–1.04
CC 46 14.5 19 13.3 0.82 0.43–1.58
Dom GG 170 53.6 65 45.5 1.00 0.09
GC-CC 147 46.4 78 54.5 0.70 0.45–1.07
Reces GG-GC 271 85.5 124 86.7 1.00 0.96
CC 46 14.5 19 13.3 0.98 0.53–1.84
Overdom GG-CC 216 68.1 84 58.7 1.00 0.09
GC 101 3.9 59 41.3 0.68 0.44–1.06
Log-additive – – – – 0.83 0.62–1.12 0.23
Allele G 443 70 189 66 1.00 0.20
C 193 30 97 34 1.24 0.90–1.71
95%CI, 95% confidence interval; Codom, codominant; Dom, dominant; OR, odds ratio;
Overdom, overdominant; Reces, recessive.
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TABLE 2 | Genotype/allele frequencies of THRH rs7832552, ACSL1
rs6552828, and IL6 rs1800795 and results of logistic regression analysis,
in the Italian cohort.
Controls Cases OR 95%CI P-value
N % N %
rs7832552
Codom CC 137 43.4 34 43.1 1.00 0.88
CT 154 48.7 40 50.6 1.06 0.64–1.72
TT 25 7.9 5 6.3 0.81 0.26–2.28
Dom CC 137 43.4 34 43.0 1.00 0.96
CT-TT 179 56.6 45 57.0 1.02 0.62–1.69
Reces CC-CT 291 92.1 74 93.7 1.00 0.64
TT 25 7.9 5 6.3 0.77 0.30–2.14
Overdom CC-TT 162 51.3 39 49.4 1.00 0.76
CT 154 48.7 40 50.6 1.09 0.68–1.75
Log-additive – – – – – 1.03 0.57–1.64 0.81
Allele C 428 68 108 68 1.00 0.88
T 204 32 50 32 0.98 0.67–1.43
rs6552828
Codom GG 121 38.3 34 43.0 1.00 0.72
GA 139 44.0 33 41.8 0.85 0.50–1.46
AA 56 17.7 12 15.2 0.77 0.35–1.55
Dom GG 121 38.3 34 43.0 1.00 0.44
GA-AA 195 61.7 45 57.0 0.83 0.51–1.37
Reces GG-GA 260 82.3 67 84.8 1.00 0.59
AA 56 17.7 12 15.2 0.85 0.43–1.65
Overdom GG-AA 177 56 46 58.2 1.00 0.72
GA 139 44 33 41.8 0.92 0.54–1.51
Log-additive – – – – – 0.84 0.46–1.47 0.80
Allele G 381 60 101 64 1.00 0.40
A 251 40 57 36 0.86 0.56–1.23
rs1800795
Codom CC 76 24.1 22 27.9 1.00 0.59
CG 160 50.6 41 51.9 0.89 0.48–1.60
GG 80 25.3 16 20.2 0.70 0.34–1.45
Dom CC 76 24.1 22 27.8 1.00 0.48
CG-GG 240 76.9 57 72.2 0.81 0.45–1.44
Reces CC-CG 236 74.7 63 79.8 1.00 0.35
GG 80 25.3 16 20.2 0.75 0.41–1.39
Overdom CC-GG 156 49.4 38 48.1 1.00 0.84
CG 160 50.6 41 51.9 1.06 0.64–1.75
Log-additive – – – – – 1.01 0.56–1.65 0.89
Allele C 312 49 85 54 1.00 0.32
G 320 51 73 46 0.84 0.57–1.19
95%CI, 95% confidence interval; Codom, codominant; Dom, dominant; OR, odds ratio;
Overdom, overdominant; Reces, recessive.
TABLE 3 | Genotype/allele frequencies of THRH rs7832552, ACSL1
rs6552828, and IL6 rs1800795 and results of logistic regression analysis,
in the Japanese cohort.
Controls Cases OR 95%CI P-value
N % N %
rs7832552
Codom CC 135 27.1 191 26.3 1.00 0.87
CT 230 46.1 351 48.3 1.06 0.81–1.41
TT 134 26.8 185 25.4 1.00 0.73–1.37
Dom CC 135 27.1 191 26.3 1.00 0.76
CT-TT 364 72.9 536 73.7 1.04 0.80–1.35
Reces CC-CT 365 73.2 542 74.5 1.00 0.77
TT 134 26.9 185 25.4 0.96 0.74–1.25
Overdom CC-TT 269 53.9 376 51.7 1.00 0.60
CT 230 46.1 351 48.3 1.06 0.84–1.34
Log-additive – – – – – 1.00 0.85–1.17 0.99
Allele C 500 50.1 733 50.4 1.00 0.99
T 498 49.9 721 49.6 0.99 0.85–1.78
rs6552828
Codom AA 186 37.6 247 34.6 1.00 0.12
GA 229 46.3 369 51.8 1.19 0.92–1.53
GG 80 16.2 97 13.6 0.85 0.59–1.21
Dom AA 186 37.6 247 34.6 1.00 0.45
GA-GG 309 62.4 466 65.4 1.10 0.86–1.40
Reces AA-GA 415 83.8 616 86.4 1.00 0.12
GG 80 16.2 97 13.6 0.77 0.56–1.07
Overdom AA-GG 266 53.7 344 48.2 1.00 0.07
GA 229 46.3 369 51.8 1.24 0.99–1.57
Log-additive – – – – 0.98 0.82–1.16 0.77
Allele A 601 61 863 61 1.00 0.78
G 386 39 563 39 0.976 0.83–1.16
rs1800795
GG 498 99.8 731 99.9 1
GC 1 0.2 1 0.1 0.84 0.05–14.09 0.9
Allele G 997 100 1463 100
C 1 0 1 0
95%CI, 95% confidence interval; Codom, codominant; Dom, dominant; OR, odds ratio;
Overdom, overdominant; Reces, recessive. Of note, logistic regression was not performed
in the Japanese cohort for rs1800795 owing to the virtual absence of C-carriers in both
groups.
Discussion
The main findings of our study are two-fold. First, all the stud-
ied SNPs showed functional significance, as reflected by the
results of the luciferase constructs. This is the first attempt to
determine (with an in vitro approach) the potential functional
Frontiers in Aging Neuroscience | www.frontiersin.org 6 May 2015 | Volume 7 | Article 59
Fuku et al. “Muscle genotypes” and exceptional longevity
consequences of the rs16892496, rs7832552, and rs6552828 SNPs,
with the A-allele, T-allele and A-allele up-regulating luciferase
activity compared to the other alleles, respectively. The THRH
rs7832552 andACSL1 rs6552828 SNPs are intronic genomic vari-
ants and, as such, could potentially alter the stability and/or
alternative splicing of mRNA, as well as transcription fac-
tor binding (Tabor et al., 2002; Knight, 2005; Mercado et al.,
2005; Sasabe et al., 2007). However, we found no association
between THRH rs7832552, IL6 rs1800795, and ACSL1 rs6552828
and EL.
Althoughmore research is obviously needed, we found no evi-
dence that higher THRH expression (as theoretically associated
with the T-allele or CT-TT genotypes vs. CC) might favor EL. Yet
a GWAS study reported that the TRHR rs7832552 SNP was asso-
ciated with lean body mass in US Caucasians (Liu et al., 2009).
Subjects carrying the theoretically highest expressing (TT) geno-
type had 2.55 kg higher lean body mass compared to the other
subjects. There is some scientific rationale in postulating that
higher TRHR expression might help preservation of muscle mass
in long-lived individuals: TRHR stimulates the hypothalamic-
pituitary-thyroid axis, thereby leading to the release of thyroxin,
a hormone that plays an important role in the development of
skeletal muscle as well as in attenuating age-related changes in
tissue function (Larsson et al., 1994). Although no association
was found here, the IL6 rs1800795 might be also a candidate
to influence EL. Carriage of the “low-producing” C-allele has
been positively associated with longevity in Turkish population
(Kayaalti et al., 2011), whereas the high-producing GG-genotype
has been linked with higher survival in elderly females from Swe-
den (Cederholm et al., 2007). On the other hand, the rs1800795
polymorphism has been linked with longevity in Italian centenar-
ians from Treviso (Albani et al., 2009) although this finding was
not replicated in other European cohorts (Di Bona et al., 2009)
(including from other parts of Italy, Albani et al., 2009), or in US
elders (Walston et al., 2009). As forACSL1 rs6552828, our data do
not show an association of this polymorphismwith EL despite the
involvement of this gene in aerobic metabolism in the heart, liver,
adipose and skeletal muscle tissues (Martin et al., 1997; Coleman
et al., 2000; Hall et al., 2003; Mashek et al., 2006; Ellis et al., 2010).
Recent research did not report an association between rs6552828
and an important age-related disease condition, the metabolic
syndrome (Phillips et al., 2010).
A strength and novelty from our design stems from the use of
a luciferase construct study to assess functionality of the 3 SNPs
at the specific muscle tissue-level. However, our study has sev-
eral limitations. First, besides the fact that we did not assess the
functionality of the SNPs in vivo in blood samples and especially
in muscle biopsies (which is understandable due to ethical rea-
sons), we used convenience samples, which increases the risk of
bias induced by population stratification. The SNPs rs1800795
and rs7832552 did not meet HWE in Spanish and Italian con-
trols, respectively. In this regard, deviation from HWE does
not necessarily reflect genotyping errors (Leal, 2005; Zou and
Donner, 2006), with ∼10% of all genotype–phenotype associa-
tion studies actually showing failure of 1+ genotype distributions
tomeet HWE (Trikalinos et al., 2006). Second, we selected 3 SNPs
based on previous GWAS, i.e., those showing associations of
rs16892496 and rs7832552 with lean body mass (Liu et al., 2009)
and of rs6552828 with VO2peak (Bouchard et al., 2011). Besides
differences in terms of population-specificity (ethic/geographic
origin, age) between these 2 GWAS and our cohorts, an addi-
tional problem is that GWAS are generally successful to find
very penetrant dominant genetic variants, but less useful to dis-
cover rarer variants, with a likely modest effect on some phe-
notypes, such as those that could be potentially associated with
EL. Finally, a potential confounder of genetic association studies
is differences in date of birth, e.g., the centenarians and con-
trols of our study were born in the early 1900s and after 1930,
respectively (Lewis and Brunner, 2004). In this regard, the poten-
tial demographic biases of longevity studies like ours perform-
ing cross-sectional comparisons of genotype/allele frequencies
between controls and long lived individuals could be overcome
by adding demographic information to genetic data (Yashin et al.,
1999; Passarino et al., 2006; Dato et al., 2007). Thus, genetic–
demographic methods should be applied in future studies in the
field because they allow the estimation of hazard rates and sur-
vival functions in relation to candidate genes (Yashin et al., 1999;
Passarino et al., 2006; Dato et al., 2007).
In summary, despite the potential functional consequences
of the SNPs we studied (rs16892496, rs7832552, and rs6552828)
none of them was associated with EL. Similarly, no association
was found for rs1800795. More research is needed in the field
with other cohorts, using larger population samples, as well as
younger elderly (e.g., aged 65–85 years) to assess the poten-
tial link between these genetic variants and the human aging
process.
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